🧪
hypothesis

APOE isoform modifies the C1q binding landscape, biasing C1q toward inflammatory plaque-associated or synaptotoxic complexes in APOE4 contexts

Hypothesis

APOE isoform modifies the C1q binding landscape, biasing C1q toward inflammatory plaque-associated or synaptotoxic complexes in APOE4 contexts

This is best treated as a stratification and response-modifier hypothesis rather than a primary C1q mechanism.
🧬 APOE,C1QA,C1QB,C1QC,TREM2,APP🩺 neurodegeneration🎯 Composite 59%💱 $0.55▼6.9%proposed
EvidencePending (0%)📖 7 cit🗣 1 debates 7 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.68 (15%) Evidence 0.55 (15%) Novelty 0.67 (12%) Feasibility 0.67 (12%) Impact 0.57 (12%) Druggability 0.48 (10%) Safety 0.49 (8%) Competition 0.52 (6%) Data Avail. 0.69 (5%) Reproducible 0.54 (5%) KG Connect 0.50 (8%) 0.590 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite59%

🧪 Overview

This is best treated as a stratification and response-modifier hypothesis rather than a primary C1q mechanism. APOE4 may alter lipid and aggregate surfaces in ways that shift C1q interactomes toward complement-amplifying complexes, but the causal chain remains loose because ApoE biology is highly pleiotropic.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["APOE4 Isoform<br/>Structural Instability"]
    B["Impaired Lipid Loading<br/>Reduced Cholesterol Efflux"]
    C["LRP1 Reduced Binding<br/>BBB Clearance Deficit"]
    D["Amyloid-beta<br/>Accumulation"]
    E["Synaptic Dysfunction<br/>Membrane Disruption"]
    F["Neurodegeneration<br/>Cognitive Decline"]
    G["APOE3 Comparison<br/>Normal Lipidation"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    G -.->|"protective"| C
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix7 supports2 contradicts
Supports
ApoE can bind C1q in inflammatory contexts, supporting a direct biochemical connection between these pathways.
PMID:30692699
Supports
APOE genotype strongly shapes AD-relevant plaque and glial biology, making C1q complex remodeling plausible as one downstream consequence.
PMID:30692699
Supports
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.
Alzheimers Dement2024PMID:39031528medium
Supports
Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms.
Neuron2021PMID:34157306medium
Supports
An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis.
Front Immunol2023PMID:38179058medium
Supports
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
Alzheimers Dement2024PMID:38375983medium
Supports
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
Alzheimers Dement2023PMID:36795776medium
Contradicts
ApoE effects may operate mainly through lipid trafficking, plaque compaction, or microglial activation upstream of C1q rather than through direct C1q-complex remodeling.
PMID:37023079
Contradicts
Isoform-specific synaptic versus plaque partitioning of C1q has not been cleanly established under controlled conditions.
PMID:30692699
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — APOE

🧬 PDB 2L7B Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for APOE,C1QA,C1QB,C1QC,TREM2,APP from GTEx v10.

Substantia nigra1881 Nucleus accumbens basal ganglia1789 Caudate basal ganglia1710 Putamen basal ganglia1612 Amygdala1348 Hypothalamus1063 Anterior cingulate cortex BA24828 Cerebellum778 Hippocampus699 Frontal Cortex BA9676 Cerebellar Hemisphere658 Cortex639 Spinal cord cervical c-1603median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for APOE,C1QA,C1QB,C1QC,TREM2,APP →

No DepMap CRISPR Chronos data found for APOE,C1QA,C1QB,C1QC,TREM2,APP.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.4%
Volatility
Low
0.0034
Events (7d)
2
Price History
▼6.9%

💾 Resource Usage

LLM Tokens
19,754
$0.0593
Total Cost
$0.0593

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF APP/PS1 mice crossed to APOE4 knock-in mice are compared to APP/PS1 × APOE3 knock-in mice at 9 months of age, THEN APOE4 brains will show significantly elevated (≥2-fold) membrane-bound C1q-C3 compAPOE4 mice will have significantly higher C1q-C3 soluble complex concentrations in brain tissue homogenates (ELISA: mean > 800 pg/mg protein vs < 400 pg/mg for — no observation —pending0.58
IF iPSC-derived microglia from APOE4/4 donors are compared to APOE3/3 iPSC-derived microglia in a co-culture assay with fluorescently labeled C1q protein under amyloid-beta42 challenge conditions (1 µAPOE4 microglia C1q interactome will show preferential association with complement amplification proteins (C1R, C3, C4B) compared to APOE3 microglia which will — no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF iPSC-derived microglia from APOE4/4 donors are compared to APOE3/3 iPSC-derived microglia in a co-culture assay with fluorescently labeled C1q protein under amyloid-beta42 challenge conditions (1 µM, 72 hours), THEN APOE4 microglia will exhibit a significantly different C1q co-immunoprecipitation
Predicted outcome: APOE4 microglia C1q interactome will show preferential association with complement amplification proteins (C1R, C3, C4B) compared to APOE3 microglia w
Falsification: No statistically significant difference (p > 0.05) in C1q co-immunoprecipitation partners between APOE4 and APOE3 genotypes; or C1q interactomes show identical complement-to-synapse protein ratios wit
pendingconf 58%
IF APP/PS1 mice crossed to APOE4 knock-in mice are compared to APP/PS1 × APOE3 knock-in mice at 9 months of age, THEN APOE4 brains will show significantly elevated (≥2-fold) membrane-bound C1q-C3 complex formation in the hippocampus as measured by native PAGE immunoblot relative to APOE3 brains.
Predicted outcome: APOE4 mice will have significantly higher C1q-C3 soluble complex concentrations in brain tissue homogenates (ELISA: mean > 800 pg/mg protein vs < 400
Falsification: APOE4 and APOE3 mice show equivalent (<1.2-fold) C1q-C3 complex levels with overlapping 95% confidence intervals; or APOE4 shows reduced rather than elevated complement complex formation.
View on SciDEX ↗